| Stephanie Ann Krape, | |
|
1708 Blackwood Dr, Knoxville, TN 37923-1105 | |
| (606) 682-3461 | |
| Not Available |
| Full Name | Stephanie Ann Krape |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 1708 Blackwood Dr, Knoxville, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003548280 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 7247 (Tennessee) | Primary |
| Provider Name | Functional Pathways Preferred Of Tennessee Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1841561446 PECOS PAC ID: 2860649654 Enrollment ID: O20121228000137 |
News Archive
Xcellerex, Inc. announced today that Project GreenVax has agreed to acquire XDR GMP single-use production bioreactors from Xcellerex. The systems will be deployed in a new facility currently under construction in Bryan, Texas. Project GreenVax is spearheaded by Texas Plant-Expressed Vaccine Consortium, which consists of G-Con, LLC and The Texas A&M University System. Financial terms were not disclosed.
Results from a study conducted by Majestic Research suggest that Bristol Myers Squibb's Orencia, Johnson & Johnson's Remicade, and Amgen's/Wyeth's Enbrel will forfeit share of the rheumatoid arthritis market to Roche's newly launched Actemra. Early switching data from Majestic's proprietary panel of rheumatologists indicates that Orencia may be the biggest loser of all, as 54% of switches to Actemra thus far have been from Orencia.
Entelos, Inc., a simulation and modeling company focused on human health, announced today that the U.S. Patent and Trademark Office has granted U.S. Patent No. 7,654,955 entitled "Apparatus and Methods for Assessing Metabolic Substrate Utilization" to the Company. These methods further strengthen the Entelos® Metabolism PhysioLab® platform and leverage insights about human physiology that can lead to improved diagnosis, clinical testing, and personalized treatment across a highly variable patient population.
A new University of Missouri study shows that the exposure to the controversial chemical Bisphenol A (BPA) through diet has been underestimated by previous lab tests.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephanie Ann Krape, 1708 Blackwood Dr, Knoxville, TN 37923-1105 Ph: (606) 682-3461 | Stephanie Ann Krape, 1708 Blackwood Dr, Knoxville, TN 37923-1105 Ph: (606) 682-3461 |
News Archive
Xcellerex, Inc. announced today that Project GreenVax has agreed to acquire XDR GMP single-use production bioreactors from Xcellerex. The systems will be deployed in a new facility currently under construction in Bryan, Texas. Project GreenVax is spearheaded by Texas Plant-Expressed Vaccine Consortium, which consists of G-Con, LLC and The Texas A&M University System. Financial terms were not disclosed.
Results from a study conducted by Majestic Research suggest that Bristol Myers Squibb's Orencia, Johnson & Johnson's Remicade, and Amgen's/Wyeth's Enbrel will forfeit share of the rheumatoid arthritis market to Roche's newly launched Actemra. Early switching data from Majestic's proprietary panel of rheumatologists indicates that Orencia may be the biggest loser of all, as 54% of switches to Actemra thus far have been from Orencia.
Entelos, Inc., a simulation and modeling company focused on human health, announced today that the U.S. Patent and Trademark Office has granted U.S. Patent No. 7,654,955 entitled "Apparatus and Methods for Assessing Metabolic Substrate Utilization" to the Company. These methods further strengthen the Entelos® Metabolism PhysioLab® platform and leverage insights about human physiology that can lead to improved diagnosis, clinical testing, and personalized treatment across a highly variable patient population.
A new University of Missouri study shows that the exposure to the controversial chemical Bisphenol A (BPA) through diet has been underestimated by previous lab tests.
› Verified 9 days ago
Shakendra Marr, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10133 Sherrill Blvd Ste 200, Knoxville, TN 37932 Phone: 865-392-2849 | |
Kelly Marie Kinne, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 10133 Sherrill Blvd Ste 200, Knoxville, TN 37932 Phone: 207-459-8838 | |
Michele Miles, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 301 S Gallaher View Rd Ste 105, Knoxville, TN 37919 Phone: 615-614-8833 | |
Brittany Powers, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2929 Tazewell Pike, Knoxville, TN 37918 Phone: 615-614-8833 Fax: 615-614-8811 | |
Crystal Henley, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 229 S Peters Rd, Knoxville, TN 37923 Phone: 865-221-1280 | |
Katherine Mckinney Pelger, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 1600 Accelerator Way Ste 220, Knoxville, TN 37920 Phone: 865-595-1940 Fax: 865-595-1945 |